NZ Researchers Who Specialise in Cancer Drug Discovery under the following disciplines:
Medicinal Chemistry and Immunotherapy
Medicinal Chemistry Research Teams
Associate Professor David Barker,
Dist Professor Margaret Brimble,
Emeritus Professor George Clark,
Professor Christian Hartinger,
Associate Professor Michael Hay,
Associate Professor Adam Patterson,
Free Radical Research Teams
Associate Professor Bob Anderson,
Professor Christine Winterbourn,
Redox activated nanoparticles: Dr Greg Giles,
Redox regulation of thiol signalling pathways: Dr Greg Giles,
Mathematics, Statistics, Informatics, Computational Modelling
Associate Professor Mik Black,
Computational modelling and design: Associate Professor Joel Tyndall,
Pharmacology and Sensitization
Associate Professor Patries Herst,
Professor Paul Teesdale-Spittle (pre-2005),
Fibrosarcoma sensitization: Dr Sarah Baird
Targeting Cancer Energetics and Metabolism
Immunotherapies and Vaccines
Dist Professor Margaret Brimble,
Vaccine delivery systems: Professor Sarah Hook
Chimeric Antigen Receptor T cells (CAR-T cells) and NK cells targeting solid tumours: Associate Professor Alexander McLellan
Fighting the cytokine storm: Associate Professor Alexander McLellan
Improving tumour T-cell infiltration: Associate Professor Alexander McLellan
Drug Delivery
Associate Professor Vyacheslav Filichev,
Nanoparticles for vaccine delivery: Professor Sarah Hook
Nanoparticles in colorectal cancer: Associate Professor Rosyln Kemp
Nanomicelles in prostate cancer: Professor Rhonda Rosengren
Hypoxia-responsive drug delivery systems: Dr Greg Giles
Molecular Biology in Drug Development
Tumour microenvironment
Associate Professor Margaret Currie,
Associate Professor Gordon Rewcastle,
Targeting of tumour microenvironment: Associate Professor Alexander McLellan
Mesenchymal stem cells in tumour micro-environment: Dr Sarah Baird
Redox molecules and signalling
Associate Professor Anitra Carr,
Associate Professor Gabi Dachs,
Oligonucleotide conjugates and nano/oligo formulations:
Signal transduction proteins and pathways
Associate Professor Gordon Rewcastle,
Associate Professor Christopher Squire,
Cell death proteins and pathways
Drug resistance pathways
Non-small cell lung cancer: Associate Professor John Ashton
Targeting drug resistance: Professor Rhonda Rosengren
Targeting invasion and metastasis
In fibrosarcoma: Dr Sarah Baird
Synthetic lethal screens and targeting
CRISPR targeting
Immune response
Associate Professor Nuala Helsby,
Pharmacogenomics
Associate Professor Nuala Helsby,